Unknown

Dataset Information

New therapeutic approaches for type 1 diabetes: Disease-modifying therapies.


ABSTRACT: It has been 100 years since the first successful clinical use of insulin, yet it remains the only treatment option for type 1 diabetes mellitus (T1DM) patients. Advances in diabetes care, such as insulin analogue therapies and new devices, including continuous glucose monitoring with continuous subcutaneous insulin infusion have improved the quality of life of patients but have no impact on the pathogenesis of the disease. They do not eliminate long-term complications and require several lifestyle sacrifices. A more ideal future therapy for T1DM, instead of supplementing the insufficient hormone production (a consequence of β-cell destruction), would also aim to stop or slow down the destructive autoimmune process. The discovery of the autoimmune nature of type 1 diabetes mellitus has pres

SUBMITTER: Nagy G 

PROVIDER: S-EPMC9606789 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature